Anomalie metaboliche Insulino-resistenza Iperattività del sistema nervoso ortosimpatico Stile di vita sedentario Disfunzione endoteliale Perdita di massa muscolare Influenza di citochine (TNF-alpha, leptina..) Iperglicemia Aumento della concentrazione degli FFA The cardiotoxic triad: Myocardial ischemia Hypertension Diabetic cardiomyopathy Stratton IM. UKPDS 35. BMJ 2000;321:405–412 Kaplan-Meier estimates of the proportion of patients with hospitalization for CHF divided into classes of glycemia at baseline (log rank P<0.001) Held, C. et al. Circulation 2007 Scompenso cardiaco, diabete e prognosi Shindler DM et al. SOLVD Trials and Registry. Am J Cardiol 1996;77:1017 EURObservational Research Program: The Heart Failure Pilot Survey (ESC-HF Pilot) Aldo P Maggioni, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jaroslaw Drozdz, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Marco Metra, John Parissis, Hans Persson, Piotr Ponikowski, Mathias Rauchhaus, Adriaan Voors, Olav Wendelboe Nielsen, Faiez Zannad, Luigi Tavazzi on the behalf of the Heart Failure Association of the ESC (HFA) Disclosures: None EURObservational Research Programme Comparison between Acute and Chronic HF: baseline characteristics CHF pts (n. 3226) AHF pts (n. 1892) 67±13 70±13 Females, % 29.7 37.3 Ischemic etiology, % 40.4 50.7 84.9 64.0 SBP (mmHg), mean±SD 125±20 133±29 HR (bpm), mean±SD 72±14 88±24 Treated hypertension, % 58.3 61.8 Diabetes mellitus, % 29.0 35.1 History of Atrial Fibrillation, % 38.6 43.7 Chronic kidney dysfunction, % 18.5 26.0 ICD, % 13.3 6.0 CRT, % 1.1 0.4 EURObservational 8.7 2.9 Research Programme Age (years), mean±SD documented by coronary angiography, % CRT-D, % EuroHeart Failure Survey Other Concomitant Diagnoses % 10.701 pts Female 47% Mean age 71 yrs EURObservational Research Programme Cleland JF et Al, European Heart Journal (2003) 24, 442–463 From: Heart Failure–Associated Hospitalizations in the United States J Am Coll Cardiol. 2013;61(12):1259-1267. doi:10.1016/j.jacc.2012.12.038 Figure Legend: Rates of Heart Failure–Related Hospitalization Annual age- and sex-adjusted rates of hospitalizations in the United States with a diagnosis of heart failure (HF) in the primary versus secondary position are shown. Date of download: 3/19/2013 Copyright © The American College of Cardiology. All rights reserved. From: Heart Failure–Associated Hospitalizations in the United States J Am Coll Cardiol. 2013;61(12):1259-1267. doi:10.1016/j.jacc.2012.12.038 No DM! Figure Legend: Trends in Prevalence of the 10 Most Common Primary Diagnoses for Heart Failure–Related Hospitalizations, Other Than Heart Failure Itself Bars represent the percent of all heart failure–related hospitalizations that were related to a given diagnosis for a 3-year period. Values of p< 0.001 for each diagnosis across all years. COPD = chronic obstructive pulmonary disease. Date of download: 3/19/2013 Copyright © The American College of Cardiology. All rights reserved. Non considerato il DM Dati UOC Fermo 2011 2012 RICOVERI SC 257 256 UOMINI 64% 61% DEG. MEDIA 8,2 7.2 ETA’ MEDIA 74,9 75 DECESSI 6% 6% PAZ CON DM 21% 15% UOMINI 58% 66% DEG. MEDIA 10,4 8,3 ETA’ MEDIA 75 77,4 DECESSI 4% 5% CONCLUSIONI • DM E SC sono frequentemente associati • Il peso della comorbilità DM nelle ospedalizzazioni è importante ma non sufficientemente indagato • Il DM è un importante determinante prognostico • Nella riduzione delle riospedalizzazioni è importante un attento controllo metabolico del diabete Domenico Gabrielli Association of noncardiac morbidities with death in CHF patients Braunstein JB et Al. J Am Coll Cardiol 2003;42:1226 –33